Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.

Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.

For young people with type 1 diabetes, hybrid closed-loop insulin delivery does not affect the rate of severe hypoglycemia and is associated with an increased risk for diabetic ketoacidosis.

Eating behavior and consuming certain foods are associated with perceived pelvic floor disorders, according to a study recently published.

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.

The FDA has filed the NDA submission for relacorilant to treat patients with Cushing syndrome (hypercortisolism).

A presidential advisory has been published by the AHA regarding US government funding for the National Institutes of Health.

For patients with obesity undergoing joint replacement, higher weight loss after initiating antiobesity medications within 1 year is associated with a lower risk for revision.

Polypharmacy is associated with poor clinical outcomes following COVID-19 infection among patients with type 2 diabetes.

Self-reported financial hardship was significantly associated with insomnia risk, poor sleep quality, and short sleep duration.

Nonmalignant gynecological diseases (NMGD) are associated with cardiovascular and/or cerebrovascular disease (C/CVD).

Researchers have found that, in the United States, adults with chronic disease, compared to those without, have worse cardiovascular health.